The potential rescheduling of marijuana from a Schedule I to a Schedule III controlled substance under the Controlled Substances Act (CSA) is a significant topic of discussion, with wide-ranging implications for the cannabis industry, including retail dispensaries, consumers, and the overall market dynamics. Implications for Marijuana Retail Dispensaries and the Buying Process for Consumers Currently,......